Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular macromolecules via reactive oxygen species-mediated damage refers to the collective oxidative degradation of DNA, proteins, and lipids caused by reactive oxygen species (ROS) such as superoxide, hydrogen peroxide, and hydroxyl radicals (Pizzino et al., 2017, Oxidative Medicine and Cellular Longevity). ROS are generated during normal mitochondrial respiration or by enzymes like NADPH oxidase, but excessive levels lead to oxidative stress, causing mutations in DNA, misfolding of proteins, and lipid peroxidation of membranes (Sies et al., 2017, Nature Reviews Molecular Cell Biology). This damage is a central driver in the pathogenesis of cancer, neurodegenerative disorders like Alzheimer's, and cardiovascular diseases (Schieber & Chandel, 2014, Current Biology). Pharmacological intervention typically involves antioxidants (e.g., N-acetylcysteine) or scavengers (e.g., Edaravone) that neutralize ROS before they can interact with these macromolecules (Forman & Zhang, 2021, Free Radical Biology and Medicine). However, because ROS also function as essential signaling molecules in processes like immune response and cell differentiation, non-specific targeting can lead to significant safety concerns and therapeutic failure (Harris & DeNicola, 2020, Nature Reviews Cancer).
Neutralization of reactive oxygen species (ROS) through scavenging, donation of electrons to stabilize free radicals, or induction of endogenous antioxidant enzymes to prevent oxidative modification of cellular components.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular macromolecules (DNA, proteins, and lipids) (ROS-mediated damage).